PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
PacBio (NASDAQ: PACB), a top developer of high-quality sequencing solutions, announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The company's management will engage in a fireside chat on Thursday, September 5, at 1:05 p.m. Eastern Time.
The event will be live-streamed on PacBio's investors page at investor.pacificbiosciences.com. For those unable to attend live, a replay will be available for at least 30 days following the event. This presentation offers investors and interested parties an opportunity to gain insights into PacBio's latest developments and future prospects in the sequencing technology sector.
PacBio (NASDAQ: PACB), un importante sviluppatore di soluzioni di sequenziamento di alta qualità, ha annunciato la sua partecipazione alla 22ª Conferenza Annuale Globale sulla Salute di Morgan Stanley. La direzione dell'azienda parteciperà a un fireside chat giovedì, 5 settembre, alle 13:05 ora orientale.
L'evento sarà trasmesso in diretta sulla pagina dedicata agli investitori di PacBio su investor.pacificbiosciences.com. Per coloro che non possono partecipare dal vivo, sarà disponibile una registrazione per almeno 30 giorni dopo l'evento. Questa presentazione offre agli investitori e alle parti interessate un'opportunità per ottenere informazioni sugli ultimi sviluppi di PacBio e sulle prospettive future nel settore della tecnologia di sequenziamento.
PacBio (NASDAQ: PACB), un destacado desarrollador de soluciones de secuenciación de alta calidad, anunció su participación en la 22.ª Conferencia Anual Global de Atención Médica de Morgan Stanley. La dirección de la empresa participará en una charla íntima el jueves 5 de septiembre a la 1:05 p.m. Hora del Este.
El evento será transmitido en vivo en la página para inversionistas de PacBio en investor.pacificbiosciences.com. Para aquellos que no puedan asistir en vivo, se estará disponible una reproducción durante al menos 30 días después del evento. Esta presentación ofrece a los inversionistas y partes interesadas la oportunidad de obtener información sobre los últimos desarrollos de PacBio y sus perspectivas futuras en el sector de la tecnología de secuenciación.
PacBio (NASDAQ: PACB), 고품질 염기 서열 분석 솔루션의 주요 개발자는 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 회사 경영진은 9월 5일 목요일 오후 1시 5분 동부 표준시에 따뜻한 대화에 참여할 것입니다.
이 행사는 PacBio의 투자자 페이지인 investor.pacificbiosciences.com에서 실시간 스트리밍됩니다. 실시간으로 참석할 수 없는 분들을 위해, 이벤트 후 최소 30일 동안 재생이 가능합니다. 이 프레젠테이션은 투자자 및 관심 있는 분들에게 PacBio의 최신 개발 및 염기 서열 분석 기술 분야의 미래 전망에 대한 통찰을 얻을 수 있는 기회를 제공합니다.
PacBio (NASDAQ: PACB), un développeur de solutions de séquençage de haute qualité, a annoncé sa participation à la 22e Conférence Annuelle Mondiale de la Santé de Morgan Stanley. La direction de l'entreprise participera à un fireside chat le jeudi 5 septembre à 13h05, heure de l'Est.
L'événement sera diffusé en direct sur la page investisseurs de PacBio à l'adresse investor.pacificbiosciences.com. Pour ceux qui ne peuvent pas assister en direct, un enregistrement sera disponible pendant au moins 30 jours après l'événement. Cette présentation offre aux investisseurs et aux parties intéressées l'occasion d'obtenir des informations sur les derniers développements de PacBio et sur les perspectives futures dans le secteur de la technologie de séquençage.
PacBio (NASDAQ: PACB), ein führender Entwickler von hochwertigen Sequenzierungslösungen, gab seine Teilnahme an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley bekannt. Das Management des Unternehmens wird am Donnerstag, den 5. September um 13:05 Uhr Eastern Time an einem Fireside-Chat teilnehmen.
Die Veranstaltung wird live gestreamt auf der Investoren-Website von PacBio unter investor.pacificbiosciences.com. Für diejenigen, die nicht live teilnehmen können, wird eine Wiedergabe für mindestens 30 Tage nach der Veranstaltung verfügbar sein. Diese Präsentation bietet Investoren und Interessierten die Möglichkeit, Einblicke in die neuesten Entwicklungen von PacBio und die zukünftigen Perspektiven im Bereich der Sequenzierungstechnologie zu erhalten.
- None.
- None.
MENLO PARK, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, at 1:05 p.m. Eastern Time.
The event will be live-streamed on the company's investors page at investor.pacificbiosciences.com. A replay will be available for at least 30 days following the event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our HiFi long-read sequencing and our SBB® short-read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
Todd Friedman
ir@pacb.com
Media:
pr@pacb.com
FAQ
When is PacBio (PACB) presenting at the Morgan Stanley Global Healthcare Conference?
How can I watch PacBio's (PACB) presentation at the Morgan Stanley conference?
Will there be a replay available of PacBio's (PACB) Morgan Stanley conference presentation?
What type of presentation will PacBio (PACB) give at the Morgan Stanley Healthcare Conference?
